Anticonvulsant hypersensitivity syndrome: a review.

Abstract excerpt

Anticonvulsant hypersensitivity syndrome (AHS), characterised by fever, rash and internal organ involvement, is a rare, but potentially fatal adverse event that occurs most commonly with first-line aromatic anticonvulsants, but can also occur with non-aromatic anticonvulsants such as lamotrigine and valproic acid. AHS can begin anywhere from 1 to 12 weeks after commencement of therapy and has been estimated to...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Anticonvulsants
• Share to Drug Hypersensitivity
• Share to Epilepsy